Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
Abbott (NYSE: ABT) today announced it’s developing a new biowearable that will continuously monitor glucose and […]
Epic Sciences Raises $43M in First Close of Series F Financing to Advance Comprehensive Profiling for Metastatic Cancer Patients
Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $43 […]
Tecartus® Car T-cell Therapy Demonstrates Strong Overall Survival Rates and Continued Durable Responses in Long-Term Follow-Up of Two Pivotal Studies Including Longest Ever Follow-Up of a CAR T-cell Therapy in Mantle Cell Lymphoma
Kite, a Gilead Company (Nasdaq: GILD), today announced longer-term follow-up results from two pivotal studies […]
New Novartis Data Show Piqray® Effectiveness Across Key Biomarkers in Patients With HR+/HER2- Metastatic Breast Cancer
Novartis today announced results of an exploratory retrospective biomarker analysis finding that different genetic mutation […]
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and GO Therapeutics, Inc. (Co-Founder […]
Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury
Aruna Bio, Inc., a leader in the development of neural exosome based therapeutics for the […]
Novavax Initiates Phase 3 Trial of its COVID-19 Omicron Strain Vaccine as a Booster
Novavax today announced the initiation of its Phase 3 strain change trial to determine if […]
Tobias Hauser Joins Limbic to Help Close UK Demand-supply Gap of Psychological Therapy
Tobias Hauser, joins Limbic as its Head of Computational Psychiatry. Hauser has worked at the […]
ETNA™ Device From the Leading Digital Health & AI Company Innodem Neurosciences Receives FDA"Breakthrough" Designation for Multiple Sclerosis
Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital […]
Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development
Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more